Cargando…

The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions

BACKGROUND: Thoracic ultrasound is an essential tool in the daily clinical care of pleural effusions and especially parapneumonic pleural effusions (PPEs), in terms of diagnosis, management, and follow-up. Hypoechogenicity index (HI) is a quantitative marker of pleural fluid echogenicity. We aimed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Varsamas, Charalampos, Kalkanis, Alexandros, Gourgoulianis, Konstantinos I., Malli, Foteini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556052/
https://www.ncbi.nlm.nih.gov/pubmed/33082889
http://dx.doi.org/10.1155/2020/1283590
_version_ 1783594150922289152
author Varsamas, Charalampos
Kalkanis, Alexandros
Gourgoulianis, Konstantinos I.
Malli, Foteini
author_facet Varsamas, Charalampos
Kalkanis, Alexandros
Gourgoulianis, Konstantinos I.
Malli, Foteini
author_sort Varsamas, Charalampos
collection PubMed
description BACKGROUND: Thoracic ultrasound is an essential tool in the daily clinical care of pleural effusions and especially parapneumonic pleural effusions (PPEs), in terms of diagnosis, management, and follow-up. Hypoechogenicity index (HI) is a quantitative marker of pleural fluid echogenicity. We aimed to examine associations of HI with pleural inflammation in patients with PPE. METHODS: All patients included underwent a thoracic ultrasound with HI determination at the first day of their admission for a PPE. Thoracentesis was performed in all patients. Demographics, laboratory measurements, and clinical data were collected prospectively and recorded in all subjects. RESULTS: Twenty-four patients with PPE were included in the study. HI was statistically significantly correlated with intensity of inflammation as suggested by pleural fluid LDH (p < 0.001, r = −0.831), pleural fluid glucose (p=0.022, r = 0.474), and pleural fluid pH (p < 0.001, r = 0.811). HI was correlated with ADA levels (p=0.005, r = −0.552). We observed a statistically significant correlation of HI with pleural fluid total cell number (p < 0.001, r = −0.657) and polymorphonuclears percentage (p=0.02, r = −0.590), as well as days to afebrile (p=0.046, r = −0.411), duration of chest tube placement (p < 0.001, r = −0.806), and days of hospitalization (p=0.013, r = −0.501). Discussion. HI presents a fast, easily applicable, objective, and quantitative marker of pleural inflammation that reliably reflects the intensity of pleural inflammation and could potentially guide therapeutic management of PPE.
format Online
Article
Text
id pubmed-7556052
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-75560522020-10-19 The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions Varsamas, Charalampos Kalkanis, Alexandros Gourgoulianis, Konstantinos I. Malli, Foteini Can Respir J Research Article BACKGROUND: Thoracic ultrasound is an essential tool in the daily clinical care of pleural effusions and especially parapneumonic pleural effusions (PPEs), in terms of diagnosis, management, and follow-up. Hypoechogenicity index (HI) is a quantitative marker of pleural fluid echogenicity. We aimed to examine associations of HI with pleural inflammation in patients with PPE. METHODS: All patients included underwent a thoracic ultrasound with HI determination at the first day of their admission for a PPE. Thoracentesis was performed in all patients. Demographics, laboratory measurements, and clinical data were collected prospectively and recorded in all subjects. RESULTS: Twenty-four patients with PPE were included in the study. HI was statistically significantly correlated with intensity of inflammation as suggested by pleural fluid LDH (p < 0.001, r = −0.831), pleural fluid glucose (p=0.022, r = 0.474), and pleural fluid pH (p < 0.001, r = 0.811). HI was correlated with ADA levels (p=0.005, r = −0.552). We observed a statistically significant correlation of HI with pleural fluid total cell number (p < 0.001, r = −0.657) and polymorphonuclears percentage (p=0.02, r = −0.590), as well as days to afebrile (p=0.046, r = −0.411), duration of chest tube placement (p < 0.001, r = −0.806), and days of hospitalization (p=0.013, r = −0.501). Discussion. HI presents a fast, easily applicable, objective, and quantitative marker of pleural inflammation that reliably reflects the intensity of pleural inflammation and could potentially guide therapeutic management of PPE. Hindawi 2020-10-05 /pmc/articles/PMC7556052/ /pubmed/33082889 http://dx.doi.org/10.1155/2020/1283590 Text en Copyright © 2020 Charalampos Varsamas et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Varsamas, Charalampos
Kalkanis, Alexandros
Gourgoulianis, Konstantinos I.
Malli, Foteini
The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions
title The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions
title_full The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions
title_fullStr The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions
title_full_unstemmed The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions
title_short The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions
title_sort use of a novel quantitative marker of echogenicity of pleural fluid in parapneumonic pleural effusions
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556052/
https://www.ncbi.nlm.nih.gov/pubmed/33082889
http://dx.doi.org/10.1155/2020/1283590
work_keys_str_mv AT varsamascharalampos theuseofanovelquantitativemarkerofechogenicityofpleuralfluidinparapneumonicpleuraleffusions
AT kalkanisalexandros theuseofanovelquantitativemarkerofechogenicityofpleuralfluidinparapneumonicpleuraleffusions
AT gourgoulianiskonstantinosi theuseofanovelquantitativemarkerofechogenicityofpleuralfluidinparapneumonicpleuraleffusions
AT mallifoteini theuseofanovelquantitativemarkerofechogenicityofpleuralfluidinparapneumonicpleuraleffusions
AT varsamascharalampos useofanovelquantitativemarkerofechogenicityofpleuralfluidinparapneumonicpleuraleffusions
AT kalkanisalexandros useofanovelquantitativemarkerofechogenicityofpleuralfluidinparapneumonicpleuraleffusions
AT gourgoulianiskonstantinosi useofanovelquantitativemarkerofechogenicityofpleuralfluidinparapneumonicpleuraleffusions
AT mallifoteini useofanovelquantitativemarkerofechogenicityofpleuralfluidinparapneumonicpleuraleffusions